[The selective reduction of nitro compounds by E. coli cells]

Area of Science:

• Medicinal Chemistry
• Microbiology
• Organic Chemistry

Background:

• Diazepine and quinoxalinone derivatives are important pharmaceutical scaffolds.
• Nitroaromatic compounds can exhibit biological activity but often require reduction for therapeutic use.
• Microbial nitroreduction offers a potentially greener and more selective synthetic route.

Purpose of the Study:

• To investigate the nitroreduction of specific dinitrophenyl-diazepine and dinitrobenzoyl-dihydroquinoxalinone compounds using E. coli.
• To characterize the resulting amino-nitro derivatives formed by microbial action.
• To confirm the transformation using a combination of analytical techniques.

Main Methods:

• Incubation of dinitro-compounds with E. coli cultures.
• Isolation and purification of reaction products.
• Identification of products using spectroscopic methods (e.g., NMR, Mass Spectrometry) and chromatographic techniques.
• Verification of nitroreduction via chemical assays.

Main Results:

• Successful nitroreduction of 2,4-dinitro-5H-11-p-R-phenyl-[b,f]-1,4-diazepines to 2-nitro-4-amino-11-p-R-phenyldibenzo-[b,f]-1,4-diazepines by E. coli.
• Successful nitroreduction of 4-(2'-R-3',5'-dinitro)benzoyl-3,4-dihydroquinoxalinones-2 to 4-(2'-R-3'-nitro-5'-amino)-benzoyl-3,4-dihydroquinoxalinones-2 by E. coli.
• Confirmation of product structures and reaction pathways through integrated physical and chemical analyses.

Conclusions:

• E. coli effectively mediates the nitroreduction of complex dinitroaromatic compounds.
• Microbial nitroreduction is a viable method for synthesizing amino-nitro derivatives of diazepines and quinoxalinones.
• This study highlights the potential of biocatalysis in the synthesis of pharmacologically relevant molecules.